Treatment of Iron Deficiency Anemia in Malaria Endemic Ghana
Seasonal Impact of Iron Fortification on Malaria Incidence in Ghanaian Children
1 other identifier
interventional
3,880
1 country
1
Brief Summary
Iron deficiency and iron deficiency anemia (IDA) are the most prevalent micronutrient deficiencies on a worldwide basis, especially in developing countries. The impact of severe IDA can have mortal consequences, since without adequate hemoglobin, the brain and body become deprived of oxygen and, if allowed to continue, death may ensue. It has been shown that iron supplementation in infants and young children can enhance child development, however, it may also result in increased rates of malaria in high burden areas. The primary objective of this study is to determine the impact of providing encapsulated iron (as a powder added to complementary foods) on the susceptibility to clinical malaria among anemic and non-anemic infants and young children (6-24 months of age) living in a high malaria burden area. The value of performing this research in Ghana is primarily that malaria and anemia remain the most important causes of death and morbidity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 21, 2009
CompletedFirst Posted
Study publicly available on registry
October 27, 2009
CompletedStudy Start
First participant enrolled
November 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2011
CompletedApril 19, 2021
April 1, 2021
11 months
October 21, 2009
April 14, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
incidence of clinical malaria (if fever recorded a blood sample will be taken to determine parasite species and count)
5 months
Secondary Outcomes (8)
changes in anemia status (blood levels of: haemoglobin(Hb) , ferritin (SF))
5 months
severity of clinical malaria (blood parasite count)
5 months
cerebral malaria (defined by a parasite count >5000/μL blood and a concurrent score of <2 on the Blantyre coma scale, with or without convulsions)
5 months
hospitalization (documentation of hospitalization for any reason)
5 months
death
5 months
- +3 more secondary outcomes
Study Arms (2)
Vitamin/mineral fortificant with iron
EXPERIMENTALVitamin/mineral fortificant without iron
PLACEBO COMPARATORInterventions
powdered vitamin/mineral fortificant WITH iron sprinkled onto food once a day for 5 months
powdered vitamin/mineral fortificant WITHOUT iron sprinkled onto food once a day for 5 months
Eligibility Criteria
You may qualify if:
- Age 6-24 months
- Ingesting weaning food in addition to breastmilk
- Free from malaria or other major illnesses
- Afebrile
- Living in Brong Ahafo Region of Ghana for duration of intervention and follow-up
You may not qualify if:
- Severe anemia (hemoglobin \<70g/L)
- Weight-for-height \<-3 z-score(severe wasting)
- Kwashiorkor (defined as evidence of edema)
- Congenital abnormality
- Treatment with iron supplements within the past 6 months
- Presence of any chronic illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kintampo Health Research Centre
Kintampo, PO Box 200, Ghana
Related Publications (5)
Tchum SK, Sakyi SA, Arthur F, Adu B, Abubakar LA, Oppong FB, Dzabeng F, Amoani B, Gyan T, Asante KP. Effect of iron fortification on anaemia and risk of malaria among Ghanaian pre-school children with haemoglobinopathies and different ABO blood groups. BMC Nutr. 2023 Mar 23;9(1):56. doi: 10.1186/s40795-023-00709-w.
PMID: 36959634DERIVEDTchum SK, Sakyi SA, Adu B, Arthur F, Oppong FB, Dzabeng F, Amoani B, Gyan T, Poku-Asante K. Impact of IgG response to malaria-specific antigens and immunity against malaria in pre-school children in Ghana. A cluster randomized, placebo-controlled trial. PLoS One. 2021 Jul 20;16(7):e0253544. doi: 10.1371/journal.pone.0253544. eCollection 2021.
PMID: 34283841DERIVEDAimone AM, Brown P, Owusu-Agyei S, Zlotkin SH, Cole DC. Impact of iron fortification on the geospatial patterns of malaria and non-malaria infection risk among young children: a secondary spatial analysis of clinical trial data from Ghana. BMJ Open. 2017 Jun 6;7(5):e013192. doi: 10.1136/bmjopen-2016-013192.
PMID: 28592572DERIVEDAimone AM, Brown PE, Zlotkin SH, Cole DC, Owusu-Agyei S. Geo-spatial factors associated with infection risk among young children in rural Ghana: a secondary spatial analysis. Malar J. 2016 Jul 8;15:349. doi: 10.1186/s12936-016-1388-1.
PMID: 27391972DERIVEDZlotkin S, Newton S, Aimone AM, Azindow I, Amenga-Etego S, Tchum K, Mahama E, Thorpe KE, Owusu-Agyei S. Effect of iron fortification on malaria incidence in infants and young children in Ghana: a randomized trial. JAMA. 2013 Sep 4;310(9):938-47. doi: 10.1001/jama.2013.277129.
PMID: 24002280DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stanley H Zlotkin, PhD
The Hospital for Sick Children, Toronto, Canada
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief, Global Child Health
Study Record Dates
First Submitted
October 21, 2009
First Posted
October 27, 2009
Study Start
November 1, 2009
Primary Completion
October 1, 2010
Study Completion
May 1, 2011
Last Updated
April 19, 2021
Record last verified: 2021-04